nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—CYP2C18—Omeprazole—Barrett's esophagus	0.243	0.316	CbGbCtD
Buprenorphine—ABCG2—Omeprazole—Barrett's esophagus	0.109	0.142	CbGbCtD
Buprenorphine—CYP2C19—Esomeprazole—Barrett's esophagus	0.0828	0.108	CbGbCtD
Buprenorphine—CYP2C8—Omeprazole—Barrett's esophagus	0.0582	0.0758	CbGbCtD
Buprenorphine—CYP2C19—Omeprazole—Barrett's esophagus	0.0488	0.0636	CbGbCtD
Buprenorphine—CYP1A2—Omeprazole—Barrett's esophagus	0.045	0.0587	CbGbCtD
Buprenorphine—CYP2C9—Omeprazole—Barrett's esophagus	0.0406	0.0529	CbGbCtD
Buprenorphine—CYP3A4—Esomeprazole—Barrett's esophagus	0.04	0.0522	CbGbCtD
Buprenorphine—ABCB1—Omeprazole—Barrett's esophagus	0.0394	0.0513	CbGbCtD
Buprenorphine—CYP2D6—Omeprazole—Barrett's esophagus	0.0371	0.0483	CbGbCtD
Buprenorphine—CYP3A4—Omeprazole—Barrett's esophagus	0.0236	0.0307	CbGbCtD
Buprenorphine—Asthma aggravated—Omeprazole—Barrett's esophagus	0.0125	0.0638	CcSEcCtD
Buprenorphine—Asthma aggravated—Esomeprazole—Barrett's esophagus	0.0125	0.0638	CcSEcCtD
Buprenorphine—Apathy—Omeprazole—Barrett's esophagus	0.00201	0.0103	CcSEcCtD
Buprenorphine—Apathy—Esomeprazole—Barrett's esophagus	0.00201	0.0103	CcSEcCtD
Buprenorphine—Flat affect—Omeprazole—Barrett's esophagus	0.00199	0.0102	CcSEcCtD
Buprenorphine—Flat affect—Esomeprazole—Barrett's esophagus	0.00199	0.0102	CcSEcCtD
Buprenorphine—Rigors—Omeprazole—Barrett's esophagus	0.00176	0.00901	CcSEcCtD
Buprenorphine—Rigors—Esomeprazole—Barrett's esophagus	0.00176	0.00901	CcSEcCtD
Buprenorphine—Accidental injury—Omeprazole—Barrett's esophagus	0.00162	0.00831	CcSEcCtD
Buprenorphine—Accidental injury—Esomeprazole—Barrett's esophagus	0.00162	0.00831	CcSEcCtD
Buprenorphine—Dysmenorrhoea—Esomeprazole—Barrett's esophagus	0.00158	0.00809	CcSEcCtD
Buprenorphine—Dysmenorrhoea—Omeprazole—Barrett's esophagus	0.00158	0.00809	CcSEcCtD
Buprenorphine—Blood pressure increased—Omeprazole—Barrett's esophagus	0.00144	0.00736	CcSEcCtD
Buprenorphine—Hiccups—Esomeprazole—Barrett's esophagus	0.00144	0.00736	CcSEcCtD
Buprenorphine—Hiccups—Omeprazole—Barrett's esophagus	0.00144	0.00736	CcSEcCtD
Buprenorphine—Blood pressure increased—Esomeprazole—Barrett's esophagus	0.00144	0.00736	CcSEcCtD
Buprenorphine—Injection site reaction—Esomeprazole—Barrett's esophagus	0.00143	0.00731	CcSEcCtD
Buprenorphine—Injection site reaction—Omeprazole—Barrett's esophagus	0.00143	0.00731	CcSEcCtD
Buprenorphine—Dry eye—Omeprazole—Barrett's esophagus	0.00133	0.00679	CcSEcCtD
Buprenorphine—Dry eye—Esomeprazole—Barrett's esophagus	0.00133	0.00679	CcSEcCtD
Buprenorphine—Ear pain—Omeprazole—Barrett's esophagus	0.00122	0.00626	CcSEcCtD
Buprenorphine—Ear pain—Esomeprazole—Barrett's esophagus	0.00122	0.00626	CcSEcCtD
Buprenorphine—Sleep disorder—Esomeprazole—Barrett's esophagus	0.0012	0.00617	CcSEcCtD
Buprenorphine—Sleep disorder—Omeprazole—Barrett's esophagus	0.0012	0.00617	CcSEcCtD
Buprenorphine—Injury—Esomeprazole—Barrett's esophagus	0.00113	0.00581	CcSEcCtD
Buprenorphine—Injury—Omeprazole—Barrett's esophagus	0.00113	0.00581	CcSEcCtD
Buprenorphine—Hot flush—Esomeprazole—Barrett's esophagus	0.00111	0.00571	CcSEcCtD
Buprenorphine—Hot flush—Omeprazole—Barrett's esophagus	0.00111	0.00571	CcSEcCtD
Buprenorphine—Menopausal symptoms—Omeprazole—Barrett's esophagus	0.0011	0.00566	CcSEcCtD
Buprenorphine—Menopausal symptoms—Esomeprazole—Barrett's esophagus	0.0011	0.00566	CcSEcCtD
Buprenorphine—Visual disturbance—Esomeprazole—Barrett's esophagus	0.0011	0.00564	CcSEcCtD
Buprenorphine—Visual disturbance—Omeprazole—Barrett's esophagus	0.0011	0.00564	CcSEcCtD
Buprenorphine—Osteoarthritis—Omeprazole—Barrett's esophagus	0.00104	0.00534	CcSEcCtD
Buprenorphine—Diplopia—Omeprazole—Barrett's esophagus	0.00104	0.00534	CcSEcCtD
Buprenorphine—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00104	0.00534	CcSEcCtD
Buprenorphine—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.00104	0.00534	CcSEcCtD
Buprenorphine—Diplopia—Esomeprazole—Barrett's esophagus	0.00104	0.00534	CcSEcCtD
Buprenorphine—Pain in extremity—Omeprazole—Barrett's esophagus	0.00104	0.00534	CcSEcCtD
Buprenorphine—Migraine—Omeprazole—Barrett's esophagus	0.00103	0.00526	CcSEcCtD
Buprenorphine—Migraine—Esomeprazole—Barrett's esophagus	0.00103	0.00526	CcSEcCtD
Buprenorphine—Face oedema—Esomeprazole—Barrett's esophagus	0.00101	0.00516	CcSEcCtD
Buprenorphine—Face oedema—Omeprazole—Barrett's esophagus	0.00101	0.00516	CcSEcCtD
Buprenorphine—Dry skin—Esomeprazole—Barrett's esophagus	0.000956	0.00489	CcSEcCtD
Buprenorphine—Dry skin—Omeprazole—Barrett's esophagus	0.000956	0.00489	CcSEcCtD
Buprenorphine—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.000952	0.00488	CcSEcCtD
Buprenorphine—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.000952	0.00488	CcSEcCtD
Buprenorphine—Breast disorder—Omeprazole—Barrett's esophagus	0.000942	0.00483	CcSEcCtD
Buprenorphine—Breast disorder—Esomeprazole—Barrett's esophagus	0.000942	0.00483	CcSEcCtD
Buprenorphine—Cramp muscle—Omeprazole—Barrett's esophagus	0.000939	0.00481	CcSEcCtD
Buprenorphine—Cramp muscle—Esomeprazole—Barrett's esophagus	0.000939	0.00481	CcSEcCtD
Buprenorphine—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000919	0.00471	CcSEcCtD
Buprenorphine—Muscular weakness—Esomeprazole—Barrett's esophagus	0.000919	0.00471	CcSEcCtD
Buprenorphine—Muscular weakness—Omeprazole—Barrett's esophagus	0.000919	0.00471	CcSEcCtD
Buprenorphine—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.000919	0.00471	CcSEcCtD
Buprenorphine—Abdominal distension—Omeprazole—Barrett's esophagus	0.000907	0.00465	CcSEcCtD
Buprenorphine—Abdominal distension—Esomeprazole—Barrett's esophagus	0.000907	0.00465	CcSEcCtD
Buprenorphine—Dysphagia—Esomeprazole—Barrett's esophagus	0.000901	0.00462	CcSEcCtD
Buprenorphine—Influenza—Omeprazole—Barrett's esophagus	0.000901	0.00462	CcSEcCtD
Buprenorphine—Influenza—Esomeprazole—Barrett's esophagus	0.000901	0.00462	CcSEcCtD
Buprenorphine—Asthma—Esomeprazole—Barrett's esophagus	0.000901	0.00462	CcSEcCtD
Buprenorphine—Asthma—Omeprazole—Barrett's esophagus	0.000901	0.00462	CcSEcCtD
Buprenorphine—Dysphagia—Omeprazole—Barrett's esophagus	0.000901	0.00462	CcSEcCtD
Buprenorphine—Bronchospasm—Esomeprazole—Barrett's esophagus	0.000886	0.00454	CcSEcCtD
Buprenorphine—Bronchospasm—Omeprazole—Barrett's esophagus	0.000886	0.00454	CcSEcCtD
Buprenorphine—Angina pectoris—Omeprazole—Barrett's esophagus	0.000878	0.0045	CcSEcCtD
Buprenorphine—Angina pectoris—Esomeprazole—Barrett's esophagus	0.000878	0.0045	CcSEcCtD
Buprenorphine—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.000837	0.00429	CcSEcCtD
Buprenorphine—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.000837	0.00429	CcSEcCtD
Buprenorphine—Weight decreased—Esomeprazole—Barrett's esophagus	0.000815	0.00418	CcSEcCtD
Buprenorphine—Weight decreased—Omeprazole—Barrett's esophagus	0.000815	0.00418	CcSEcCtD
Buprenorphine—Infestation NOS—Omeprazole—Barrett's esophagus	0.000803	0.00412	CcSEcCtD
Buprenorphine—Infestation—Omeprazole—Barrett's esophagus	0.000803	0.00412	CcSEcCtD
Buprenorphine—Infestation NOS—Esomeprazole—Barrett's esophagus	0.000803	0.00412	CcSEcCtD
Buprenorphine—Infestation—Esomeprazole—Barrett's esophagus	0.000803	0.00412	CcSEcCtD
Buprenorphine—Depression—Esomeprazole—Barrett's esophagus	0.000801	0.0041	CcSEcCtD
Buprenorphine—Depression—Omeprazole—Barrett's esophagus	0.000801	0.0041	CcSEcCtD
Buprenorphine—Urinary tract infection—Omeprazole—Barrett's esophagus	0.000781	0.004	CcSEcCtD
Buprenorphine—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.000781	0.004	CcSEcCtD
Buprenorphine—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000781	0.004	CcSEcCtD
Buprenorphine—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000781	0.004	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00076	0.00389	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00076	0.00389	CcSEcCtD
Buprenorphine—Sinusitis—Esomeprazole—Barrett's esophagus	0.000754	0.00386	CcSEcCtD
Buprenorphine—Sinusitis—Omeprazole—Barrett's esophagus	0.000754	0.00386	CcSEcCtD
Buprenorphine—Bradycardia—Esomeprazole—Barrett's esophagus	0.000734	0.00376	CcSEcCtD
Buprenorphine—Bradycardia—Omeprazole—Barrett's esophagus	0.000734	0.00376	CcSEcCtD
Buprenorphine—Rhinitis—Esomeprazole—Barrett's esophagus	0.000723	0.0037	CcSEcCtD
Buprenorphine—Rhinitis—Omeprazole—Barrett's esophagus	0.000723	0.0037	CcSEcCtD
Buprenorphine—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000718	0.00368	CcSEcCtD
Buprenorphine—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000718	0.00368	CcSEcCtD
Buprenorphine—Hallucination—Esomeprazole—Barrett's esophagus	0.000718	0.00368	CcSEcCtD
Buprenorphine—Hallucination—Omeprazole—Barrett's esophagus	0.000718	0.00368	CcSEcCtD
Buprenorphine—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000716	0.00367	CcSEcCtD
Buprenorphine—Pharyngitis—Omeprazole—Barrett's esophagus	0.000716	0.00367	CcSEcCtD
Buprenorphine—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000712	0.00365	CcSEcCtD
Buprenorphine—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000712	0.00365	CcSEcCtD
Buprenorphine—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00071	0.00364	CcSEcCtD
Buprenorphine—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00071	0.00364	CcSEcCtD
Buprenorphine—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.000709	0.00363	CcSEcCtD
Buprenorphine—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.000709	0.00363	CcSEcCtD
Buprenorphine—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000707	0.00362	CcSEcCtD
Buprenorphine—Urethral disorder—Omeprazole—Barrett's esophagus	0.000707	0.00362	CcSEcCtD
Buprenorphine—Visual impairment—Omeprazole—Barrett's esophagus	0.000695	0.00356	CcSEcCtD
Buprenorphine—Visual impairment—Esomeprazole—Barrett's esophagus	0.000695	0.00356	CcSEcCtD
Buprenorphine—Eye disorder—Esomeprazole—Barrett's esophagus	0.000674	0.00345	CcSEcCtD
Buprenorphine—Eye disorder—Omeprazole—Barrett's esophagus	0.000674	0.00345	CcSEcCtD
Buprenorphine—Tinnitus—Omeprazole—Barrett's esophagus	0.000672	0.00344	CcSEcCtD
Buprenorphine—Tinnitus—Esomeprazole—Barrett's esophagus	0.000672	0.00344	CcSEcCtD
Buprenorphine—Flushing—Omeprazole—Barrett's esophagus	0.000669	0.00343	CcSEcCtD
Buprenorphine—Flushing—Esomeprazole—Barrett's esophagus	0.000669	0.00343	CcSEcCtD
Buprenorphine—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000651	0.00334	CcSEcCtD
Buprenorphine—Immune system disorder—Omeprazole—Barrett's esophagus	0.000651	0.00334	CcSEcCtD
Buprenorphine—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00065	0.00333	CcSEcCtD
Buprenorphine—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00065	0.00333	CcSEcCtD
Buprenorphine—Chills—Esomeprazole—Barrett's esophagus	0.000647	0.00331	CcSEcCtD
Buprenorphine—Chills—Omeprazole—Barrett's esophagus	0.000647	0.00331	CcSEcCtD
Buprenorphine—Mental disorder—Omeprazole—Barrett's esophagus	0.000632	0.00324	CcSEcCtD
Buprenorphine—Mental disorder—Esomeprazole—Barrett's esophagus	0.000632	0.00324	CcSEcCtD
Buprenorphine—Malnutrition—Omeprazole—Barrett's esophagus	0.000628	0.00322	CcSEcCtD
Buprenorphine—Malnutrition—Esomeprazole—Barrett's esophagus	0.000628	0.00322	CcSEcCtD
Buprenorphine—Flatulence—Omeprazole—Barrett's esophagus	0.000619	0.00317	CcSEcCtD
Buprenorphine—Flatulence—Esomeprazole—Barrett's esophagus	0.000619	0.00317	CcSEcCtD
Buprenorphine—Tension—Esomeprazole—Barrett's esophagus	0.000616	0.00316	CcSEcCtD
Buprenorphine—Tension—Omeprazole—Barrett's esophagus	0.000616	0.00316	CcSEcCtD
Buprenorphine—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000615	0.00315	CcSEcCtD
Buprenorphine—Dysgeusia—Omeprazole—Barrett's esophagus	0.000615	0.00315	CcSEcCtD
Buprenorphine—Nervousness—Omeprazole—Barrett's esophagus	0.00061	0.00312	CcSEcCtD
Buprenorphine—Nervousness—Esomeprazole—Barrett's esophagus	0.00061	0.00312	CcSEcCtD
Buprenorphine—Back pain—Omeprazole—Barrett's esophagus	0.000607	0.00311	CcSEcCtD
Buprenorphine—Back pain—Esomeprazole—Barrett's esophagus	0.000607	0.00311	CcSEcCtD
Buprenorphine—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000604	0.00309	CcSEcCtD
Buprenorphine—Muscle spasms—Omeprazole—Barrett's esophagus	0.000604	0.00309	CcSEcCtD
Buprenorphine—Vision blurred—Omeprazole—Barrett's esophagus	0.000592	0.00303	CcSEcCtD
Buprenorphine—Vision blurred—Esomeprazole—Barrett's esophagus	0.000592	0.00303	CcSEcCtD
Buprenorphine—Tremor—Esomeprazole—Barrett's esophagus	0.000588	0.00301	CcSEcCtD
Buprenorphine—Tremor—Omeprazole—Barrett's esophagus	0.000588	0.00301	CcSEcCtD
Buprenorphine—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000583	0.00298	CcSEcCtD
Buprenorphine—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000583	0.00298	CcSEcCtD
Buprenorphine—Agitation—Omeprazole—Barrett's esophagus	0.000577	0.00296	CcSEcCtD
Buprenorphine—Agitation—Esomeprazole—Barrett's esophagus	0.000577	0.00296	CcSEcCtD
Buprenorphine—Angioedema—Omeprazole—Barrett's esophagus	0.000574	0.00294	CcSEcCtD
Buprenorphine—Angioedema—Esomeprazole—Barrett's esophagus	0.000574	0.00294	CcSEcCtD
Buprenorphine—Malaise—Esomeprazole—Barrett's esophagus	0.000566	0.0029	CcSEcCtD
Buprenorphine—Malaise—Omeprazole—Barrett's esophagus	0.000566	0.0029	CcSEcCtD
Buprenorphine—Vertigo—Omeprazole—Barrett's esophagus	0.000564	0.00289	CcSEcCtD
Buprenorphine—Vertigo—Esomeprazole—Barrett's esophagus	0.000564	0.00289	CcSEcCtD
Buprenorphine—Palpitations—Omeprazole—Barrett's esophagus	0.000555	0.00284	CcSEcCtD
Buprenorphine—Palpitations—Esomeprazole—Barrett's esophagus	0.000555	0.00284	CcSEcCtD
Buprenorphine—Cough—Omeprazole—Barrett's esophagus	0.000548	0.00281	CcSEcCtD
Buprenorphine—Cough—Esomeprazole—Barrett's esophagus	0.000548	0.00281	CcSEcCtD
Buprenorphine—Hypertension—Esomeprazole—Barrett's esophagus	0.000542	0.00278	CcSEcCtD
Buprenorphine—Hypertension—Omeprazole—Barrett's esophagus	0.000542	0.00278	CcSEcCtD
Buprenorphine—Myalgia—Omeprazole—Barrett's esophagus	0.000534	0.00274	CcSEcCtD
Buprenorphine—Chest pain—Esomeprazole—Barrett's esophagus	0.000534	0.00274	CcSEcCtD
Buprenorphine—Arthralgia—Omeprazole—Barrett's esophagus	0.000534	0.00274	CcSEcCtD
Buprenorphine—Myalgia—Esomeprazole—Barrett's esophagus	0.000534	0.00274	CcSEcCtD
Buprenorphine—Chest pain—Omeprazole—Barrett's esophagus	0.000534	0.00274	CcSEcCtD
Buprenorphine—Arthralgia—Esomeprazole—Barrett's esophagus	0.000534	0.00274	CcSEcCtD
Buprenorphine—Anxiety—Omeprazole—Barrett's esophagus	0.000533	0.00273	CcSEcCtD
Buprenorphine—Anxiety—Esomeprazole—Barrett's esophagus	0.000533	0.00273	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000531	0.00272	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000531	0.00272	CcSEcCtD
Buprenorphine—Discomfort—Omeprazole—Barrett's esophagus	0.000528	0.00271	CcSEcCtD
Buprenorphine—Discomfort—Esomeprazole—Barrett's esophagus	0.000528	0.00271	CcSEcCtD
Buprenorphine—Dry mouth—Omeprazole—Barrett's esophagus	0.000523	0.00268	CcSEcCtD
Buprenorphine—Dry mouth—Esomeprazole—Barrett's esophagus	0.000523	0.00268	CcSEcCtD
Buprenorphine—Confusional state—Esomeprazole—Barrett's esophagus	0.000517	0.00265	CcSEcCtD
Buprenorphine—Confusional state—Omeprazole—Barrett's esophagus	0.000517	0.00265	CcSEcCtD
Buprenorphine—OPRL1—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.000515	0.0138	CbGpPWpGaD
Buprenorphine—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000512	0.00262	CcSEcCtD
Buprenorphine—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000512	0.00262	CcSEcCtD
Buprenorphine—Infection—Esomeprazole—Barrett's esophagus	0.000509	0.00261	CcSEcCtD
Buprenorphine—Infection—Omeprazole—Barrett's esophagus	0.000509	0.00261	CcSEcCtD
Buprenorphine—Shock—Esomeprazole—Barrett's esophagus	0.000504	0.00258	CcSEcCtD
Buprenorphine—Shock—Omeprazole—Barrett's esophagus	0.000504	0.00258	CcSEcCtD
Buprenorphine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000504	0.0135	CbGpPWpGaD
Buprenorphine—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000502	0.00257	CcSEcCtD
Buprenorphine—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000502	0.00257	CcSEcCtD
Buprenorphine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000501	0.0134	CbGpPWpGaD
Buprenorphine—Tachycardia—Omeprazole—Barrett's esophagus	0.0005	0.00256	CcSEcCtD
Buprenorphine—Tachycardia—Esomeprazole—Barrett's esophagus	0.0005	0.00256	CcSEcCtD
Buprenorphine—Skin disorder—Omeprazole—Barrett's esophagus	0.000498	0.00255	CcSEcCtD
Buprenorphine—Skin disorder—Esomeprazole—Barrett's esophagus	0.000498	0.00255	CcSEcCtD
Buprenorphine—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000495	0.00254	CcSEcCtD
Buprenorphine—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000495	0.00254	CcSEcCtD
Buprenorphine—CYP2A6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000494	0.0132	CbGpPWpGaD
Buprenorphine—Anorexia—Omeprazole—Barrett's esophagus	0.000488	0.0025	CcSEcCtD
Buprenorphine—Anorexia—Esomeprazole—Barrett's esophagus	0.000488	0.0025	CcSEcCtD
Buprenorphine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00047	0.0125	CbGpPWpGaD
Buprenorphine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00047	0.0125	CbGpPWpGaD
Buprenorphine—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000467	0.00239	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000467	0.00239	CcSEcCtD
Buprenorphine—CYP2C19—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000466	0.0125	CbGpPWpGaD
Buprenorphine—Insomnia—Esomeprazole—Barrett's esophagus	0.000463	0.00237	CcSEcCtD
Buprenorphine—Insomnia—Omeprazole—Barrett's esophagus	0.000463	0.00237	CcSEcCtD
Buprenorphine—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00046	0.00236	CcSEcCtD
Buprenorphine—Paraesthesia—Omeprazole—Barrett's esophagus	0.00046	0.00236	CcSEcCtD
Buprenorphine—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000457	0.00234	CcSEcCtD
Buprenorphine—Dyspnoea—Omeprazole—Barrett's esophagus	0.000457	0.00234	CcSEcCtD
Buprenorphine—Somnolence—Omeprazole—Barrett's esophagus	0.000456	0.00233	CcSEcCtD
Buprenorphine—Somnolence—Esomeprazole—Barrett's esophagus	0.000456	0.00233	CcSEcCtD
Buprenorphine—Dyspepsia—Omeprazole—Barrett's esophagus	0.000451	0.00231	CcSEcCtD
Buprenorphine—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000451	0.00231	CcSEcCtD
Buprenorphine—Decreased appetite—Omeprazole—Barrett's esophagus	0.000445	0.00228	CcSEcCtD
Buprenorphine—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000445	0.00228	CcSEcCtD
Buprenorphine—CYP3A7—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000443	0.0118	CbGpPWpGaD
Buprenorphine—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000442	0.00227	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000442	0.00227	CcSEcCtD
Buprenorphine—Fatigue—Omeprazole—Barrett's esophagus	0.000442	0.00226	CcSEcCtD
Buprenorphine—Fatigue—Esomeprazole—Barrett's esophagus	0.000442	0.00226	CcSEcCtD
Buprenorphine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000439	0.0117	CbGpPWpGaD
Buprenorphine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000439	0.0117	CbGpPWpGaD
Buprenorphine—Constipation—Esomeprazole—Barrett's esophagus	0.000438	0.00224	CcSEcCtD
Buprenorphine—Pain—Esomeprazole—Barrett's esophagus	0.000438	0.00224	CcSEcCtD
Buprenorphine—Constipation—Omeprazole—Barrett's esophagus	0.000438	0.00224	CcSEcCtD
Buprenorphine—Pain—Omeprazole—Barrett's esophagus	0.000438	0.00224	CcSEcCtD
Buprenorphine—OPRL1—G alpha (i) signalling events—SST—Barrett's esophagus	0.000434	0.0116	CbGpPWpGaD
Buprenorphine—CYP3A5—Irinotecan Pathway—APC—Barrett's esophagus	0.000432	0.0115	CbGpPWpGaD
Buprenorphine—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000425	0.0114	CbGpPWpGaD
Buprenorphine—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000422	0.00216	CcSEcCtD
Buprenorphine—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000422	0.00216	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000419	0.00215	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000419	0.00215	CcSEcCtD
Buprenorphine—Urticaria—Esomeprazole—Barrett's esophagus	0.000407	0.00209	CcSEcCtD
Buprenorphine—Urticaria—Omeprazole—Barrett's esophagus	0.000407	0.00209	CcSEcCtD
Buprenorphine—CYP2A6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000406	0.0108	CbGpPWpGaD
Buprenorphine—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000405	0.00207	CcSEcCtD
Buprenorphine—Body temperature increased—Omeprazole—Barrett's esophagus	0.000405	0.00207	CcSEcCtD
Buprenorphine—Abdominal pain—Omeprazole—Barrett's esophagus	0.000405	0.00207	CcSEcCtD
Buprenorphine—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000405	0.00207	CcSEcCtD
Buprenorphine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000395	0.0106	CbGpPWpGaD
Buprenorphine—CYP3A5—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00039	0.0104	CbGpPWpGaD
Buprenorphine—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000378	0.00193	CcSEcCtD
Buprenorphine—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000378	0.00193	CcSEcCtD
Buprenorphine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000375	0.01	CbGpPWpGaD
Buprenorphine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000375	0.01	CbGpPWpGaD
Buprenorphine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—Barrett's esophagus	0.000373	0.00997	CbGpPWpGaD
Buprenorphine—Asthenia—Esomeprazole—Barrett's esophagus	0.000368	0.00188	CcSEcCtD
Buprenorphine—Asthenia—Omeprazole—Barrett's esophagus	0.000368	0.00188	CcSEcCtD
Buprenorphine—CYP1A2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000363	0.00971	CbGpPWpGaD
Buprenorphine—Pruritus—Omeprazole—Barrett's esophagus	0.000363	0.00186	CcSEcCtD
Buprenorphine—Pruritus—Esomeprazole—Barrett's esophagus	0.000363	0.00186	CcSEcCtD
Buprenorphine—CYP2C18—Biological oxidations—CYP26A1—Barrett's esophagus	0.000354	0.00946	CbGpPWpGaD
Buprenorphine—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000351	0.0018	CcSEcCtD
Buprenorphine—Diarrhoea—Omeprazole—Barrett's esophagus	0.000351	0.0018	CcSEcCtD
Buprenorphine—CYP2C18—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000349	0.00933	CbGpPWpGaD
Buprenorphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000345	0.00922	CbGpPWpGaD
Buprenorphine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000342	0.00914	CbGpPWpGaD
Buprenorphine—Dizziness—Omeprazole—Barrett's esophagus	0.000339	0.00174	CcSEcCtD
Buprenorphine—Dizziness—Esomeprazole—Barrett's esophagus	0.000339	0.00174	CcSEcCtD
Buprenorphine—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000338	0.00902	CbGpPWpGaD
Buprenorphine—Vomiting—Omeprazole—Barrett's esophagus	0.000326	0.00167	CcSEcCtD
Buprenorphine—Vomiting—Esomeprazole—Barrett's esophagus	0.000326	0.00167	CcSEcCtD
Buprenorphine—Rash—Esomeprazole—Barrett's esophagus	0.000323	0.00165	CcSEcCtD
Buprenorphine—Rash—Omeprazole—Barrett's esophagus	0.000323	0.00165	CcSEcCtD
Buprenorphine—Dermatitis—Esomeprazole—Barrett's esophagus	0.000323	0.00165	CcSEcCtD
Buprenorphine—Dermatitis—Omeprazole—Barrett's esophagus	0.000323	0.00165	CcSEcCtD
Buprenorphine—Headache—Omeprazole—Barrett's esophagus	0.000321	0.00164	CcSEcCtD
Buprenorphine—Headache—Esomeprazole—Barrett's esophagus	0.000321	0.00164	CcSEcCtD
Buprenorphine—CYP3A5—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00032	0.00856	CbGpPWpGaD
Buprenorphine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000305	0.00816	CbGpPWpGaD
Buprenorphine—Nausea—Esomeprazole—Barrett's esophagus	0.000304	0.00156	CcSEcCtD
Buprenorphine—Nausea—Omeprazole—Barrett's esophagus	0.000304	0.00156	CcSEcCtD
Buprenorphine—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000302	0.00807	CbGpPWpGaD
Buprenorphine—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000301	0.00805	CbGpPWpGaD
Buprenorphine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000289	0.00773	CbGpPWpGaD
Buprenorphine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000289	0.00773	CbGpPWpGaD
Buprenorphine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000281	0.0075	CbGpPWpGaD
Buprenorphine—UGT1A9—Biological oxidations—CYP26A1—Barrett's esophagus	0.00028	0.00748	CbGpPWpGaD
Buprenorphine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000279	0.00744	CbGpPWpGaD
Buprenorphine—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000277	0.00741	CbGpPWpGaD
Buprenorphine—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000277	0.00741	CbGpPWpGaD
Buprenorphine—UGT1A9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000276	0.00737	CbGpPWpGaD
Buprenorphine—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000275	0.00734	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR ligand binding—SST—Barrett's esophagus	0.000263	0.00702	CbGpPWpGaD
Buprenorphine—OPRL1—Circadian rythm related genes—PPARG—Barrett's esophagus	0.000251	0.00671	CbGpPWpGaD
Buprenorphine—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000248	0.00661	CbGpPWpGaD
Buprenorphine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000238	0.00636	CbGpPWpGaD
Buprenorphine—CYP3A7—Biological oxidations—CYP26A1—Barrett's esophagus	0.000235	0.00629	CbGpPWpGaD
Buprenorphine—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000235	0.00627	CbGpPWpGaD
Buprenorphine—CYP3A7—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000232	0.0062	CbGpPWpGaD
Buprenorphine—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000228	0.00608	CbGpPWpGaD
Buprenorphine—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000226	0.00603	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.00022	0.00587	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—GAST—Barrett's esophagus	0.000217	0.00579	CbGpPWpGaD
Buprenorphine—CYP2A6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000216	0.00576	CbGpPWpGaD
Buprenorphine—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000201	0.00536	CbGpPWpGaD
Buprenorphine—OPRL1—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.000201	0.00536	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—GAST—Barrett's esophagus	0.000197	0.00526	CbGpPWpGaD
Buprenorphine—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000193	0.00515	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.000193	0.00515	CbGpPWpGaD
Buprenorphine—OPRD1—G alpha (i) signalling events—SST—Barrett's esophagus	0.000185	0.00495	CbGpPWpGaD
Buprenorphine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000184	0.00491	CbGpPWpGaD
Buprenorphine—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000181	0.00484	CbGpPWpGaD
Buprenorphine—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	0.00017	0.00454	CbGpPWpGaD
Buprenorphine—OPRL1—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.000169	0.00452	CbGpPWpGaD
Buprenorphine—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000168	0.00448	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.000163	0.00435	CbGpPWpGaD
Buprenorphine—OPRK1—G alpha (i) signalling events—SST—Barrett's esophagus	0.000163	0.00434	CbGpPWpGaD
Buprenorphine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000155	0.00413	CbGpPWpGaD
Buprenorphine—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000149	0.00398	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—SST—Barrett's esophagus	0.000149	0.00397	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000147	0.00394	CbGpPWpGaD
Buprenorphine—CYP2C8—Biological oxidations—CYP26A1—Barrett's esophagus	0.000147	0.00394	CbGpPWpGaD
Buprenorphine—UGT1A9—NRF2 pathway—HGF—Barrett's esophagus	0.000147	0.00391	CbGpPWpGaD
Buprenorphine—CYP2C8—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000145	0.00388	CbGpPWpGaD
Buprenorphine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000144	0.00386	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000142	0.00379	CbGpPWpGaD
Buprenorphine—OPRM1—G alpha (i) signalling events—SST—Barrett's esophagus	0.000137	0.00367	CbGpPWpGaD
Buprenorphine—ABCG2—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.000137	0.00366	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—SST—Barrett's esophagus	0.000135	0.0036	CbGpPWpGaD
Buprenorphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000135	0.00359	CbGpPWpGaD
Buprenorphine—UGT1A9—PPARA activates gene expression—PPARG—Barrett's esophagus	0.000132	0.00352	CbGpPWpGaD
Buprenorphine—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	0.000132	0.00351	CbGpPWpGaD
Buprenorphine—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00013	0.00347	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000129	0.00345	CbGpPWpGaD
Buprenorphine—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	0.000129	0.00344	CbGpPWpGaD
Buprenorphine—CYP2A6—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.000125	0.00333	CbGpPWpGaD
Buprenorphine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000123	0.0033	CbGpPWpGaD
Buprenorphine—OPRM1—TCR Signaling Pathway—RELA—Barrett's esophagus	0.000122	0.00327	CbGpPWpGaD
Buprenorphine—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000121	0.00323	CbGpPWpGaD
Buprenorphine—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.00012	0.0032	CbGpPWpGaD
Buprenorphine—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000119	0.00319	CbGpPWpGaD
Buprenorphine—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000118	0.00316	CbGpPWpGaD
Buprenorphine—OPRL1—Circadian rythm related genes—TP53—Barrett's esophagus	0.000118	0.00314	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—GAST—Barrett's esophagus	0.000116	0.00311	CbGpPWpGaD
Buprenorphine—CYP2A6—NRF2 pathway—HGF—Barrett's esophagus	0.000113	0.00302	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—SST—Barrett's esophagus	0.000112	0.003	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000109	0.00292	CbGpPWpGaD
Buprenorphine—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000103	0.00274	CbGpPWpGaD
Buprenorphine—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	0.000102	0.00274	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000102	0.00274	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000102	0.00272	CbGpPWpGaD
Buprenorphine—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000101	0.0027	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—SST—Barrett's esophagus	9.84e-05	0.00263	CbGpPWpGaD
Buprenorphine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	9.52e-05	0.00254	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—GAST—Barrett's esophagus	9.26e-05	0.00247	CbGpPWpGaD
Buprenorphine—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	9.15e-05	0.00244	CbGpPWpGaD
Buprenorphine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	8.88e-05	0.00237	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	8.56e-05	0.00229	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—GAST—Barrett's esophagus	8.41e-05	0.00224	CbGpPWpGaD
Buprenorphine—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	8.34e-05	0.00223	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—SST—Barrett's esophagus	8.32e-05	0.00222	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—GAST—Barrett's esophagus	8.12e-05	0.00217	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PTGES—Barrett's esophagus	7.99e-05	0.00213	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—SST—Barrett's esophagus	7.97e-05	0.00213	CbGpPWpGaD
Buprenorphine—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	7.91e-05	0.00211	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	7.84e-05	0.00209	CbGpPWpGaD
Buprenorphine—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	7.8e-05	0.00208	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	7.62e-05	0.00204	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	7.51e-05	0.00201	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.47e-05	0.00199	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—GAST—Barrett's esophagus	7.37e-05	0.00197	CbGpPWpGaD
Buprenorphine—OPRD1—G alpha (i) signalling events—CXCL8—Barrett's esophagus	7.22e-05	0.00193	CbGpPWpGaD
Buprenorphine—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	7.13e-05	0.0019	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—GAST—Barrett's esophagus	6.86e-05	0.00183	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.67e-05	0.00178	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	6.35e-05	0.00169	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—SST—Barrett's esophagus	6.34e-05	0.00169	CbGpPWpGaD
Buprenorphine—OPRK1—G alpha (i) signalling events—CXCL8—Barrett's esophagus	6.33e-05	0.00169	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PTGES—Barrett's esophagus	6.32e-05	0.00169	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	6.25e-05	0.00167	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—GAST—Barrett's esophagus	6.23e-05	0.00166	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.08e-05	0.00162	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—CYP26A1—Barrett's esophagus	6.06e-05	0.00162	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	6.01e-05	0.0016	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—CXCL8—Barrett's esophagus	5.79e-05	0.00155	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—SST—Barrett's esophagus	5.76e-05	0.00154	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.74e-05	0.00153	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—SST—Barrett's esophagus	5.56e-05	0.00149	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	5.51e-05	0.00147	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTGES—Barrett's esophagus	5.36e-05	0.00143	CbGpPWpGaD
Buprenorphine—OPRM1—G alpha (i) signalling events—CXCL8—Barrett's esophagus	5.35e-05	0.00143	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTGES—Barrett's esophagus	5.31e-05	0.00142	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—CXCL8—Barrett's esophagus	5.26e-05	0.0014	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	5.19e-05	0.00139	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—SST—Barrett's esophagus	5.05e-05	0.00135	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.04e-05	0.00134	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—GAST—Barrett's esophagus	4.97e-05	0.00133	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTGES—Barrett's esophagus	4.87e-05	0.0013	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CYP26A1—Barrett's esophagus	4.79e-05	0.00128	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—SST—Barrett's esophagus	4.7e-05	0.00126	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—CXCL8—Barrett's esophagus	4.37e-05	0.00117	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—SLC9A1—Barrett's esophagus	4.36e-05	0.00117	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—GAST—Barrett's esophagus	4.35e-05	0.00116	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—SST—Barrett's esophagus	4.27e-05	0.00114	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.26e-05	0.00114	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—APC—Barrett's esophagus	4.22e-05	0.00113	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CYP26A1—Barrett's esophagus	4.06e-05	0.00108	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	4.03e-05	0.00108	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CYP26A1—Barrett's esophagus	4.03e-05	0.00108	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTGES—Barrett's esophagus	3.84e-05	0.00103	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—CXCL8—Barrett's esophagus	3.83e-05	0.00102	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CYP26A1—Barrett's esophagus	3.69e-05	0.000985	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—GAST—Barrett's esophagus	3.68e-05	0.000983	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.54e-05	0.000945	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—SLC9A1—Barrett's esophagus	3.45e-05	0.000922	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—SST—Barrett's esophagus	3.4e-05	0.000909	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3.38e-05	0.000903	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTGES—Barrett's esophagus	3.33e-05	0.000888	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—RELA—Barrett's esophagus	3.3e-05	0.00088	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—CXCL8—Barrett's esophagus	3.24e-05	0.000866	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CXCL8—Barrett's esophagus	3.11e-05	0.00083	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	3.06e-05	0.000816	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SST—Barrett's esophagus	2.98e-05	0.000797	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGES—Barrett's esophagus	2.97e-05	0.000793	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—SLC9A1—Barrett's esophagus	2.93e-05	0.000782	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	2.91e-05	0.000777	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—SLC9A1—Barrett's esophagus	2.9e-05	0.000775	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGES—Barrett's esophagus	2.9e-05	0.000774	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.78e-05	0.000743	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGES—Barrett's esophagus	2.73e-05	0.000729	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGES—Barrett's esophagus	2.71e-05	0.000723	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—SLC9A1—Barrett's esophagus	2.66e-05	0.00071	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SST—Barrett's esophagus	2.52e-05	0.000674	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	2.52e-05	0.000673	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.47e-05	0.00066	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGES—Barrett's esophagus	2.31e-05	0.000618	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	2.25e-05	0.000601	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CXCL8—Barrett's esophagus	2.24e-05	0.000599	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	2.2e-05	0.000586	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.17e-05	0.000579	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	2.1e-05	0.00056	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	2.07e-05	0.000553	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.05e-05	0.000548	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PPARG—Barrett's esophagus	1.99e-05	0.000532	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CXCL8—Barrett's esophagus	1.97e-05	0.000526	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TP53—Barrett's esophagus	1.91e-05	0.000509	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.86e-05	0.000497	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.83e-05	0.000489	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	1.82e-05	0.000486	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	1.82e-05	0.000485	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—APC—Barrett's esophagus	1.8e-05	0.000481	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGES—Barrett's esophagus	1.79e-05	0.000477	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	1.75e-05	0.000468	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CXCL8—Barrett's esophagus	1.66e-05	0.000444	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.66e-05	0.000444	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	1.62e-05	0.000433	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	1.58e-05	0.000423	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—APC—Barrett's esophagus	1.58e-05	0.000422	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PPARG—Barrett's esophagus	1.58e-05	0.000421	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PTGS2—Barrett's esophagus	1.57e-05	0.000419	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.52e-05	0.000405	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	1.49e-05	0.000398	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.48e-05	0.000395	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.46e-05	0.000391	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—RELA—Barrett's esophagus	1.41e-05	0.000376	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.35e-05	0.000361	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PPARG—Barrett's esophagus	1.34e-05	0.000357	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—APC—Barrett's esophagus	1.33e-05	0.000356	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CXCL8—Barrett's esophagus	1.33e-05	0.000354	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PPARG—Barrett's esophagus	1.32e-05	0.000354	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.31e-05	0.000349	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.3e-05	0.000346	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	1.26e-05	0.000337	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PTGS2—Barrett's esophagus	1.24e-05	0.000331	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—RELA—Barrett's esophagus	1.23e-05	0.000329	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PPARG—Barrett's esophagus	1.21e-05	0.000324	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.19e-05	0.000318	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CXCL8—Barrett's esophagus	1.16e-05	0.00031	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTGS2—Barrett's esophagus	1.05e-05	0.000281	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—RELA—Barrett's esophagus	1.04e-05	0.000278	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTGS2—Barrett's esophagus	1.04e-05	0.000278	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.02e-05	0.000272	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCL8—Barrett's esophagus	9.83e-06	0.000262	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	9.75e-06	0.00026	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PPARG—Barrett's esophagus	9.58e-06	0.000256	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTGS2—Barrett's esophagus	9.55e-06	0.000255	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PPARG—Barrett's esophagus	8.29e-06	0.000222	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TP53—Barrett's esophagus	8.14e-06	0.000217	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	7.53e-06	0.000201	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PPARG—Barrett's esophagus	7.4e-06	0.000198	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PPARG—Barrett's esophagus	7.23e-06	0.000193	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TP53—Barrett's esophagus	7.13e-06	0.000191	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PPARG—Barrett's esophagus	6.81e-06	0.000182	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PPARG—Barrett's esophagus	6.75e-06	0.00018	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	6.52e-06	0.000174	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TP53—Barrett's esophagus	6.03e-06	0.000161	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	5.82e-06	0.000156	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PPARG—Barrett's esophagus	5.77e-06	0.000154	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGS2—Barrett's esophagus	5.68e-06	0.000152	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	5.36e-06	0.000143	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	5.31e-06	0.000142	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	4.54e-06	0.000121	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PPARG—Barrett's esophagus	4.45e-06	0.000119	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	3.5e-06	9.35e-05	CbGpPWpGaD
